Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG , a world leader in offering medicines to protect health, treat disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. Novartis is the only company with leadership positions in both patented and generic pharmaceuticals. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

* Known as Gl
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:4/17/2015)... 2015 CVS Health Corporation (NYSE: CVS ... May 1, 2015, at 8:30 a.m. (EDT) with analysts ... An audio webcast of the conference call ... of the CVS Health website for all interested parties. ... webcast will be archived and available on the web ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ... Testing - Global Strategic Business Report" report to ... markets for ADME-Toxicology Testing in US$ Million by the ... Testing. The report provides separate comprehensive analytics ... Japan , Europe , ...
(Date:4/17/2015)... DIEGO , April 17, 2015  Trovagene, ... diagnostics, announced today that clinical data presented at ... that its urine-based Precision Cancer Monitoring ℠ ... and monitoring of EGFR T790M mutations ... Detection of EGFR T790M Mutation in Urinary ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... Intravenous Recombinant Factor IX (rFIX) Product for the Treatment ... Biopharmaceuticals, Inc., today announced the initiation of a Phase ... Factor IX (rFIX) product for control and prevention of ... is estimated that the market for therapies to treat ...
... the risk of cardiovascular hospitalization or death by 24 ... Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and ... that the ATHENA trial was published in the New ... (dronedarone), in addition to standard therapy, significantly reduced the ...
Cached Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 3New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 4New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 5New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 6
(Date:4/19/2015)... 2015 A live auction will be held ... major hospital in Brooklyn, NY and other national consignors. Various ... lab, anesthesia, exam and much more. , The auction ... starting at 9:00am CDT each day. The equipment is at ... Park, IL 60160. Anyone can participate in the auction ...
(Date:4/18/2015)... For some people, tattoos are works of ... rest of their lives, as they have spent a great ... a great amount of thought on their designs. For others, ... them or simply want them removed for personal or professional ... and in 2012-13 there was a 43 percent increase in ...
(Date:4/18/2015)... April 18, 2015 Carinsurancehints.com has released a ... plans that offer financial protection against fire damage. ... pay benefits in case their vehicle is set intentionally on ... caused by rioting or by other things. , It ... on a single website http://www.carinsurancehints.com/ , in just ...
(Date:4/18/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining the ... prices . , Drivers who live in states ... to pay more for auto insurance plans that provide ... offer protection against vehicle theft. , Affordable auto ... single website: http://lowcostcarinsuranceprice.com/ . Drivers who own ...
(Date:4/18/2015)... More than 2000 styles of newly designed ... #1 online store carrying celebrity inspired special occasion dresses. ... their perfect dresses for their prom. For those who ... at TheCelebrityDresses.com would be an ideal choice. , ... dresses inspired by the most loved styles seen at ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... researchers have found that flu strains migrate back and forth ... This is contrary to the common belief that flu strains ... The research appeared online on Nov. 14 in ... It was supported in part by the Centers of ...
... first study using magnetic resonance imaging (MRI) to evaluate ... researchers from Mount Sinai School of Medicine have found ... to the initial dust cloud on September 11, 2001, ... data was presented at the American Heart Association,s Scientific ...
... Emory University School of Medicine have identified hepcidin, a ... a potential target for treating atherosclerosis. Suppressing hepcidin ... the white blood cells found in arterial plaques. Reducing ... cholesterol in a process called "reverse cholesterol transport," interfering ...
... HealthDay Reporter , TUESDAY, Nov. 15 (HealthDay News) -- ... immediately following the New York City terror attacks on Sept. ... warn. Those Ground Zero workers who got there first ... those who came on the scene after Sept. 13, and may ...
... stable cardiovascular disease who have a genetic variation that ... the standard daily dosage of this medication resulted in ... JAMA . The study is being released early ... Heart Association Scientific Sessions. "Variants in the ...
... international clinical trial has found that treatment with a ... delay the development of bone metastases in men with ... in The Lancet , is the first to ... the importance of targeting the bone microenvironment to prevent ...
Cached Medicine News:Health News:NIH grantees rebut theory that seasonal flu strains originate in tropical regions 2Health News:NIH grantees rebut theory that seasonal flu strains originate in tropical regions 3Health News:WTC workers exposed earlier to dust cloud have higher risk of atherosclerotic lesions 2Health News:Hormone that controls iron levels may be target for atherosclerosis treatment 2Health News:9/11 First Responders May Face Greater Heart Risks 2Health News:9/11 First Responders May Face Greater Heart Risks 3Health News:Increasing dosage of clopidogrel for patients with genetic variation improves response to medication 2Health News:Denosumab delays development of prostate cancer bone metastasis 2
... some sectioning work, it is necessary to cool ... Freezer can be fitted to most microtomes and ... or lower, depending on conditions. The equipment consists ... The cooling stage is best suited for operation ...
... new type of freezer designed to rapidly freeze ... rapid freezer tank which can hold object holders ... specimens. ,The Clini-RF eliminates the need to use ... liquid nitrogen. In order to save power, the ...
... MNL 4404 & 4405 series Freezing Stages ... devices have no moving parts and need only ... water for operation. Freezing starts immediately ... is adjustable so that optimum cutting temperatures can ...
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum...
Medicine Products: